Qiming Venture Partners

The firm manages around $9.5B. That capital backs Qiming Venture Partners's thesis across AI companies — from early-stage rounds through growth-stage follow-ons.

Qiming Venture Partners concentrates on AI, Health, Enterprise, China. That focus has shaped a portfolio of companies building at the intersection of these areas.

Qiming Venture Partners has backed at least 3 AI companies that Awaira tracks. Venture portfolios often include undisclosed bets, so the true count could be larger.

Most of Qiming Venture Partners's capital goes into Early Stage rounds. This stage preference aligns with their fund structure and return expectations.

Among Qiming Venture Partners's portfolio, the standout deal is Qiming Venture Partners is a early-stage venture capital firm founded in 2006, headquartered in China, managing approximately $9.5B in assets under management. The firm concentrates on AI, Health, Enterprise, China, deploying capital primarily at the early stage level. Notable AI portfolio companies include Xiaomi, Meituan, Bilibili. Qiming Venture Partners has participated in 1 funding round tracked by Awaira, deploying capital across AI, Health, Enterprise sectors. The firm's investment strategy emphasizes AI applications in healthcare and life sciences. Awaira assigns Qiming Venture Partners an investor score of 76/100 based on portfolio strength, AI sector exposure, and market activity. The firm investment thesis centers on identifying AI companies that demonstrate strong technical moats, clear paths to revenue, and potential for category leadership within their respective segments. Qiming Venture Partners evaluates opportunities based on team quality, market timing, technology differentiation, and capital efficiency. Portfolio companies including Xiaomi, Meituan, Bilibili reflect the firm emphasis on backing founders who combine deep technical expertise with commercial execution capability.. This investment reflects the firm's broader strategy and risk appetite in the AI market.